Navigation Links
Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen
Date:12/3/2009

NANJING, China, Dec. 3 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").

On November 23, 2009, Simcere urged the board of Jiangsu Yanshen to replace its general manager and head of quality assurance. Jiangsu Yanshen subsequently decided to implement a total suspension of production in order to improve its quality control systems effective on November 30, 2009.

The SFDA issued a public notice on December 3, 2009 announcing the initiation of a comprehensive investigation into quality issues regarding human use rabies vaccine manufactured by two companies including Jiangsu Yanshen. The SFDA has assigned investigation teams to oversee the provincial administrations' inquiry into the matter and has established a file on Jiangsu Yanshen. Four batches of the human use rabies vaccine manufactured by Jiangsu Yanshen between July and October 2008 have been found to have quality problems. The SFDA has ordered Jiangsu Yanshen to halt marketing and production of all products including human use rabies vaccine and has organized experts to provide an assessment of risks presented by the problem vaccine. According to the SFDA announcement, patients who received the vaccine in question may receive medical consultations with their original inoculation hospitals. The resumption of production and sales at Jiangsu Yanshen as well as potentia
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Simcere Pharmaceutical Group Announces Jiangsu Yanshens Voluntary Suspension of Production
2. Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.
3. Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals
4. Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
5. Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals
6. KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van Vliet
7. Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends
8. Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities
9. Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies
10. Lilly Releases Latest Value of Medicine Resource Guide About Key Issues Facing the Pharmaceutical Industry
11. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)...  Today, ATS Labs, Inc. (ATS), majority owned by ... of MicroTest Labs, Inc. (MTL) of Agawam ... first step in the strategy of ATS to expand ... the medical device and biopharmaceutical industries.  The combined companies ... , a name that personifies the quality and accuracy ...
(Date:7/14/2014)... , July 14, 2014 ... a technology partnership with global bioengineering leader ... technology for quick-to-market products. The ... DNA2.0,s machine learning optimization technologies, such as ... the process of engineering proteins in the ...
(Date:7/14/2014)... , July 14, 2014 BioAdaptives, Inc. (OTCBB:BDPT) ... Chairman has assumed the roles of President and CEO ... Ferris Holding, Inc., the company that licensed its formulation, ... its financial supporter. "Mr. Gerald ... early transition as a privately held entity to a ...
Breaking Medicine Technology:ATS Labs, Inc. Announces the Acquisition of MicroTest Labs, Inc. 2ATS Labs, Inc. Announces the Acquisition of MicroTest Labs, Inc. 3Pareto Biotechnologies Announces Technology Partnership With DNA2.0, Inc. 2Pareto Biotechnologies Announces Technology Partnership With DNA2.0, Inc. 3BioAdaptives Prepares for Next Step 2
... COLD SPRING HARBOR, N.Y., Nov. 4, 2010 AccuVein ... illumination system, announced today that it had been awarded ... Project (QTDP) program.  This Federal grant program supports projects ... unmet medical needs, and reduce the long-term growth of ...
... the leading developer of radiology workflow solutions, today ... a joint venture between Inland Imaging and Providence ... system with Medicalis, federated productivity and quality platform ... these two proven solutions will enable radiologists who ...
Cached Medicine Technology:AccuVein Receives Grant for its Award Winning AV300 Vein Illumination System 2Medicalis Acquires RadWorkFlow from Inland Imaging and Providence Health Care 2Medicalis Acquires RadWorkFlow from Inland Imaging and Providence Health Care 3
(Date:7/14/2014)... 14, 2014 The inability to ignore irrelevant stimuli ... by individuals diagnosed with schizophrenia, reports a new study ... , Our brains are usually good at focusing on ... filtering out the "noise" or thoughts that aren,t relevant. ... part to a problem with this filtering process, which ...
(Date:7/14/2014)... 2014)In the 2,500+ years that have passed since ... it has been used to treat a number ... and vomiting, stroke rehabilitation, headaches, menstrual cramps, asthma, ... a few. Now, a meta-analysis of randomized ... in Menopause , the journal of The ...
(Date:7/14/2014)... 2014 According to a recent ... have discovered a connection between women with high levels ... infertility. Although doctors have theorized about the role stress ... study to provide scientific support. , “Stress, if very ... Dr. Larry Barmat, an OB/GYN who specializes in reproductive ...
(Date:7/14/2014)... Philadelphia, PA (PRWEB) July 14, 2014 ... and software solutions to healthcare problems have been ... ’s first Digital Health Accelerator (DHA). , ... 69 applicants via a multi-stage process. They include ... and two overseas companies—Keosys (from France) and Pulse ...
(Date:7/14/2014)... Royal Academy, senescent is he who "begins to age". ... only is senescence not a synonym of ageing, it ... senescence is such a badly named physiological process that ... needs another name. That is the case of Manuel ... one of the world,s leading experts on senescence, who ...
Breaking Medicine News(10 mins):Health News:'Noisy' memory in schizophrenia 2Health News:Bothered by hot flashes? Acupuncture might be the answer 2Health News:Abington Health Physician Addresses Link Between Stress and Infertility 2Health News:Abington Health Physician Addresses Link Between Stress and Infertility 3Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 2Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 3Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 4Health News:Manuel Serrano proposes a new vision of a process wrongly associated with ageing 2Health News:Manuel Serrano proposes a new vision of a process wrongly associated with ageing 3
... have identified two genes believed to play a role in ... to better diagnosis and treatment of this increasingly common form ... or womb cancer, is the most common malignant cancer of ... of cases being detected has increased markedly, as has mortality. ...
... While studying an HIV protein that plays an essential ... Pittsburgh School of Medicine have discovered compounds that show ... drug discovery efforts have met with little success in ... factor, called Nef, because it lacks biochemical activity that ...
... how your eyes adjust during a blackout? When we go ... must quickly adjust. Vision scientists at Washington University School of ... allows the human eye to adapt to darkness very quickly. ... bright light. The discovery could contribute to better understanding ...
... treatments instead, study finds, , TUESDAY, Oct. 13 (HealthDay News) ... cancer are not turning to mastectomy as their first choice ... as lumpectomy, a new survey has found. , The survey, ... of the American Medical Association , also found that U.S. ...
... ... Support for the Nationwide Health Information Network. , ... Chantilly, VA (PRWEB) October 13, 2009 -- Agilex Technologies, Inc. , ... and public sectors , today announced the appointment of Melissa Chapman to the ...
... fastest-growing retailer of authentic nonfat frozen yogurt, announced it ... , to celebrate the favorite food of the fall ... Spice frozen yogurt, available at all Red Mango ... 13, through December 31, 2009. , (Photo: ...
Cached Medicine News:Health News:Genes behind increasingly common form of cancer identified 2Health News:Pitt researchers find candidates for new HIV drugs 2Health News:Researchers discover mechanism that helps humans see in bright and low light 2Health News:Researchers discover mechanism that helps humans see in bright and low light 3Health News:Mastectomy Not First Choice for Most Breast Cancer Patients 2Health News:Mastectomy Not First Choice for Most Breast Cancer Patients 3Health News:Agilex Technologies Hires Former HHS CIO Melissa Chapman to Lead Health Technology Programs 2Health News:Agilex Technologies Hires Former HHS CIO Melissa Chapman to Lead Health Technology Programs 3Health News:Discover Red Mango's New Seasonal Flavor: Pumpkin Spice 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: